Clear measures blood glucose levels in real-time using a chip-implanted arm patch and an app.
Clear has raised $2.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in September 2025.
Clear's investors include Antler, Rabobank, Future Food Fund, Invest International, Healthy.Capital.
Clear is headquartered in Amsterdam, The Netherlands.
Clear measures blood glucose levels in real-time using a chip-implanted arm patch and an app.
Clear is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Clear — Funding & Investors." VCBacked, September 29, 2025, https://www.vcbacked.co/company/clear-amsterdam. Accessed October 22, 2026.
VCBacked. (2025). Clear — Funding & Investors. Retrieved October 22, 2026, from https://www.vcbacked.co/company/clear-amsterdam
{{cite web |title=Clear — Funding & Investors |url=https://www.vcbacked.co/company/clear-amsterdam |website=VCBacked |access-date=October 22, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated